We are not able to explain this biological phenomenon and it is also likely that this is not specific for Adalimumab neither for childhood uveitis, since other anti-TNF agents in different diseases (i.e. Rheumatoid Arthritis) can do the same. This evidence concerns the gene TNF and uveitis.